Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rivaroxaban”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02497716
What this trial is testing

Phase I Study on Rivaroxaban Granules for Oral Suspension Formulation in Children

Who this might be right for
Thrombosis
Bayer 47
Not applicableEnded earlyNCT03977363
What this trial is testing

The Portuguese Survey on Anticoagulated Patients Register (START-Portugal-Register)

Who this might be right for
Atrial FibrillationVenous ThromboembolismHeart Valve Diseases or Prosthesis
CHAD 25
Testing effectiveness (Phase 2)Study completedNCT03178864
What this trial is testing

Study of Rivaroxaban for CeREbral Venous Thrombosis

Who this might be right for
Cerebral Venous Thrombosis
University of British Columbia 55
Large-scale testing (Phase 3)Study completedNCT02555111
What this trial is testing

Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis.

Who this might be right for
Deep Vein ThrombosisChronic Portal Vein Thrombosis
Assistance Publique - Hôpitaux de Paris 112
Post-approval studies (Phase 4)Study completedNCT02584660
What this trial is testing

Rivaroxaban for Early Discharge of Low Risk Pulmonary Embolism From the Emergency Department

Who this might be right for
Pulmonary Embolism
Janssen Scientific Affairs, LLC 114
Not applicableStudy completedNCT02599259
What this trial is testing

Using Artificial Intelligence to Measure and Optimize Adherence in Patients on Anticoagulation Therapy.

Who this might be right for
Stroke
AiCure 28
Not applicableActive Not RecruitingNCT06193863
What this trial is testing

An Observational Study to Learn More About How Safe Rivaroxaban is And How Well it Works in Children With Congenital Heart Disease Who Had a Heart Surgery Called the Fontan Procedure

Who this might be right for
Prevention of Venous ThromboembolismCongenital Heart DiseaseFontan Procedure+1 more
Bayer 61
Early research (Phase 1)Study completedNCT01400646
What this trial is testing

Explore the Pharmacodynamic Changes When Transitioning From Rivaroxaban to Warfarin in Healthy Volunteers

Who this might be right for
Healthy
Janssen Research & Development, LLC 46
Not applicableStudy completedNCT04174859
What this trial is testing

Study Aims to Collect Information in Routine Clinical Practice in Italy About the Number of Patients Suffering From Irregularly Heart Beats Which Are Not Caused by a Heart Valve Problem (Non-valvular Atrial Fibrillation, NVAF) Who Stopped or Changed Rivaroxaban Treatment

Who this might be right for
Non-valvular Atrial Fibrillation
Bayer 812
Large-scale testing (Phase 3)Study completedNCT02926170
What this trial is testing

Rivaroxaban for Patients With Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid Syndrome
Hospital Universitari Vall d'Hebron Research Institute 190
Not applicableStudy completedNCT02975453
What this trial is testing

Study of Major Cardiovascular Events in Patients With Nonvalvular Atrial Fibrillation Treated With Rivaroxaban

Who this might be right for
Atrial Fibrillation
Bayer 1,481
Not applicableStudy completedNCT04505475
What this trial is testing

Oral Surgery in Patients Taking Direct Oral Anticoagulants

Who this might be right for
Anticoagulants and Bleeding DisordersSurgeryPostoperative Hemorrhage+1 more
University of Novi Sad 82
Testing effectiveness (Phase 2)Study completedNCT00973323
What this trial is testing

BAY59-7939 Japanese in Atrial Fibrillation (2nd)

Who this might be right for
Atrial Fibrillation
Bayer 100
Not applicableActive Not RecruitingNCT02921022
What this trial is testing

Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic CancerAdvanced Pancreatic Ductal Adenocarcinoma
Memorial Sloan Kettering Cancer Center 110
Not applicableStudy completedNCT02584842
What this trial is testing

Rivaroxaban in Endovenous Laser Ablation With and Without Miniphlebectomy

Who this might be right for
Varicose VeinsVenous ThrombosisThromboembolism+1 more
University Hospital, Basel, Switzerland 400
Not applicableStudy completedNCT01704053
What this trial is testing

Effect of New Oral Anticoagulants Dabigatran and Rivaroxaban on Point of Care Coagulation Testing - an Ex-Vivo Study

Who this might be right for
Clot Formation and Platelet Aggregation in Point of Care Testing
Johann Wolfgang Goethe University Hospital 34
Early research (Phase 1)Ended earlyNCT02058199
What this trial is testing

Rivaroxaban Effects in Subjects Who Have Undergone Gastric Bypass Surgery

Who this might be right for
Gastric Bypass Status
State University of New York - Upstate Medical University 2
Very early researchLooking for participantsNCT07832578
What this trial is testing

Comparison of Aspirin Alone Versus Low-Dose Rivaroxaban Plus Aspirin in Chronic Limb-Threatening Ischemia

Who this might be right for
Limb Ischemia
King Edward Medical University 78
Large-scale testing (Phase 3)Study completedNCT04075240
What this trial is testing

VTE Prevention Following Total Hip and Knee Arthroplasty

Who this might be right for
Venous Thromboembolism
Sudeep Shivakumar 5,429
Not applicableStudy completedNCT03254147
What this trial is testing

Medical Need of OAC Reversal

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 53,969
Next Page